This Article Full Text Full Text (PDF) All Versions of this Article: 36/12/2577    most recent 01.STR.0000190834.00284.fdv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iglseder, B. Articles by Paulweber, B. Search for Related Content PubMed PubMed Citation Articles by Iglseder, B. Articles by Paulweber, B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Carotid Artery Disease

(Stroke. 2005;36:2577.)
© 2005 American Heart Association, Inc.

Original Contributions

Plasma Adiponectin Levels and Sonographic Phenotypes of Subclinical Carotid Artery Atherosclerosis

Data From the SAPHIR Study

Bernhard Iglseder, MD; Vitolds Mackevics, MD; Andreas Stadlmayer, MD; Gernot Tasch, MD; Gunther Ladurner, MD Bernhard Paulweber, MD

From the Departments of Neurology (B.I., G.L.) and Neuroradiology (G.T.), and the First Department of Internal Medicine (V.M., A.S., B.P.), Christian Doppler Klinik, Landeskliniken and Paracelsus Private Medical University, Salzburg, Austria.

Correspondence to Bernhard Iglseder, MD, Department of Neurology, Christian Doppler Klinik, Landeskliniken and Paracelsus Private Medical University, Ignaz-Harrer-Strasse 79, A-5020 Salzburg, Austria. E-mail b.iglseder{at}salk.at

Background and Purpose— Adipose tissue produces and secretes a number of bioactive molecules, conceptualized as adipocytokines. Adiponectin has been identified as one of the adipocytokines, and hypoadiponectinemia was demonstrated in patients with obesity, diabetes mellitus, and coronary artery disease. Whether decreased adiponectin levels are cause or consequence is an important issue in the discussion on the association between adiponectin and atherosclerosis. In the present study, we investigated the association of plasma adiponectin levels with sonographic phenotypes of subclinical atherosclerosis, which may represent different stages of disease as well as common and distinct determinants.

Methods— A total of 1515 middle-aged healthy white subjects (940 males and 575 females) were included. Common carotid artery intima-media thickness (CIMT) and presence of atherosclerotic plaques were assessed by B-mode ultrasound.

Results— After adjustment for established risk factors, per 1 µg/mL decrease in adiponectin CIMT increased on the average by 3.48 µm in males (95% CI, 1.23 to 5.73 µm) and by 2.39 µm in females (95% CI, 0.50 to 4.27 µm). After dichotomizing adiponectin levels at the median and adjustment for established risk factors, the mean difference of CIMT between subjects with low and high adiponectin levels was 20.42 µm in men (95% CI, 6.80 to 34.04; P=0.003) and 20.75 µm in women (95% CI, 1.08 to 40.42; P=0.039). No significant relationship was found between adiponectin levels and presence of atherosclerotic plaques.

Conclusion— Our results demonstrate an independent negative association of adiponectin levels and CIMT, whereas no relationship with presence of atherosclerotic plaques was found, thus suggesting hypoadiponectinemia as a risk factor in the development of early atherosclerosis.

Key Words: adiponectin • atherosclerosis • carotid arteries • intima-media thickness • risk factors

This article has been cited by other articles:

				N. Zhang, Y.-H. Shi, C.-F. Hao, H. F Gu, Y. Li, Y.-R. Zhao, L.-C. Wang, and Z.-J. Chen Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women Eur. J. Endocrinol., February 1, 2008; 158(2): 255 - 260. [Abstract] [Full Text] [PDF]

				P. M. Nilsson Is adiponectin and its genetic regulators useful or not for prediction of carotid intima-media thickness and coronary heart disease? Eur. Heart J., February 1, 2008; 29(3): 293 - 295. [Full Text] [PDF]

				R. R. S. Packard and P. Libby Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction Clin. Chem., January 1, 2008; 54(1): 24 - 38. [Abstract] [Full Text] [PDF]

				V. Beauloye, F. Zech, H. Tran Thi Mong, P. Clapuyt, M. Maes, and S. M. Brichard Determinants of Early Atherosclerosis in Obese Children and Adolescents J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3025 - 3032. [Abstract] [Full Text] [PDF]

				D.C.Y. Yeung, A. Xu, C.W.S. Cheung, N.M.S. Wat, M.H. Yau, C.H.Y. Fong, M.T. Chau, and K.S.L. Lam Serum Adipocyte Fatty Acid-Binding Protein Levels Were Independently Associated With Carotid Atherosclerosis Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1796 - 1802. [Abstract] [Full Text] [PDF]

				P. E. Szmitko, H. Teoh, D. J. Stewart, and S. Verma Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1655 - H1663. [Abstract] [Full Text] [PDF]

				L. Qiao and J. Shao SIRT1 Regulates Adiponectin Gene Expression through Foxo1-C/Enhancer-binding Protein {alpha} Transcriptional Complex J. Biol. Chem., December 29, 2006; 281(52): 39915 - 39924. [Abstract] [Full Text] [PDF]

				P. M. Nilsson, G. Engstrom, B. Hedblad, J. Frystyk, M. M. Persson, G. Berglund, and A. Flyvbjerg Plasma Adiponectin Levels in Relation to Carotid Intima Media Thickness and Markers of Insulin Resistance Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2758 - 2762. [Abstract] [Full Text] [PDF]

				H. H. Hegener, I-M. Lee, N. R. Cook, P. M. Ridker, and R. Y.L. Zee Association of Adiponectin Gene Variations with Risk of Incident Myocardial Infarction and Ischemic Stroke: A Nested Case-Control Study Clin. Chem., November 1, 2006; 52(11): 2021 - 2027. [Abstract] [Full Text] [PDF]

				S. Pilz, K. Sargsyan, and H. Mangge Hypoadiponectinemia as a Risk Factor for Atherosclerosis? Stroke, July 1, 2006; 37(7): 1642 - 1642. [Full Text] [PDF]